Aurobindo Pharma Acquires Non-Oncology Prescription Business of Khandelwal Labs for Rs 325 Crore
Aurobindo Pharma has acquired the non-oncology prescription business of Khandelwal Laboratories Pvt Ltd for a cash consideration of Rs 325 crore, strengthening its presence in the domestic formulations market.